| Dr Patrice N Pearson, MD | |
|
1000 Corporate Center Dr, Suite 200, Morrow, GA 30260-4180 | |
| (770) 968-6464 | |
| Not Available |
| Full Name | Dr Patrice N Pearson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 1000 Corporate Center Dr, Morrow, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356581052 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 061932 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Cobb Hospital | Austell, GA | Hospital |
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| Wellstar Spalding Regional Hospital | Griffin, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
Alzheimer's disease (AD), affecting millions worldwide, is the leading cause of dementia. The prevalence of AD is rapidly increasing, and will possibly affect over 100 million people by 2050, yet there are no effective therapies for the disease.
A brain imaging study has shown that, after they overcome their reading disability, the brains of formerly poor readers begin to function like the brains of good readers, showing increased activity in a part of the brain that recognizes words.
Sudden unexpected death in epilepsy (SUDEP) is concerning and many—even those with seizure disorders—may not be aware of this condition. New research published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), reports that 76% of caregivers are more likely to have heard of SUDEP compared with 65% of patients with epilepsy.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
› Verified 4 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Alzheimer's disease (AD), affecting millions worldwide, is the leading cause of dementia. The prevalence of AD is rapidly increasing, and will possibly affect over 100 million people by 2050, yet there are no effective therapies for the disease.
A brain imaging study has shown that, after they overcome their reading disability, the brains of formerly poor readers begin to function like the brains of good readers, showing increased activity in a part of the brain that recognizes words.
Sudden unexpected death in epilepsy (SUDEP) is concerning and many—even those with seizure disorders—may not be aware of this condition. New research published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), reports that 76% of caregivers are more likely to have heard of SUDEP compared with 65% of patients with epilepsy.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrice N Pearson, MD 1000 Corporate Center Dr, Suite 200, Morrow, GA 30260-4180 Ph: (770) 968-6464 | Dr Patrice N Pearson, MD 1000 Corporate Center Dr, Suite 200, Morrow, GA 30260-4180 Ph: (770) 968-6464 |
News Archive
Alzheimer's disease (AD), affecting millions worldwide, is the leading cause of dementia. The prevalence of AD is rapidly increasing, and will possibly affect over 100 million people by 2050, yet there are no effective therapies for the disease.
A brain imaging study has shown that, after they overcome their reading disability, the brains of formerly poor readers begin to function like the brains of good readers, showing increased activity in a part of the brain that recognizes words.
Sudden unexpected death in epilepsy (SUDEP) is concerning and many—even those with seizure disorders—may not be aware of this condition. New research published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), reports that 76% of caregivers are more likely to have heard of SUDEP compared with 65% of patients with epilepsy.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
› Verified 4 days ago
Rana Botlani Esfahani, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1000 Corporate Center Dr, Ste 200, Morrow, GA 30260 Phone: 770-968-6464 | |
Alvin H Webster, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6522 Peacock Blvd, Morrow, GA 30260 Phone: 678-778-4591 Fax: 770-961-0056 | |
Dr. Evelyn Campbell-bayaan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1331 Mount Zion Rd, Morrow, GA 30260 Phone: 770-629-3217 | |
Rhonda R. Freeman, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 2005 Mount Zion Rd, Morrow, GA 30260 Phone: 770-919-5250 | |
Dr. George W Brown Iv, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Corporate Center Dr, Ste 200, Morrow, GA 30260 Phone: 770-968-6464 Fax: 770-968-6455 | |
Dr. Mark Mcelhannon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Corporate Center Dr, Suite 200, Morrow, GA 30260 Phone: 770-968-6464 Fax: 770-968-6455 | |
Gabriella Eliese Maris, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Corporate Center Dr, Suite 200, Morrow, GA 30260 Phone: 770-968-6464 Fax: 770-968-6455 |